Treatment of Digital Ulcers in Korean Patients With Systemic Sclerosis: a Prospective Cohort Study
NCT02642146 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 71
Last updated 2020-11-10
Summary
This study evaluates the efficacy and safety of routine medical treatments of digital ulcers in patients with systemic sclerosis in a prospective cohort study.
Conditions
- Raynaud Disease
- Systemic Sclerosis
- Digital Ulcer
Interventions
- DRUG
-
Calcium Channel Blockers
- DRUG
-
Phosphodiesterase Inhibitors
- DRUG
-
Endothelin receptor blocker
- DRUG
-
Prostanoids
- DRUG
-
Other vasodilator
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-31
- Primary Completion
- 2019-06-30
- Completion
- 2019-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Treatment Outcome of Autologous PRP Versus Conventional Therapy Among Patients With Chronic Venous Leg Ulcers
NCT05974982 ·Status: COMPLETED ·Phase: PHASE1
-
PRP Versus PRF Versus Conventional Treatment in Chronic Non-healing Skin Ulcers
NCT06281483 ·Status: RECRUITING ·Phase: NA
-
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers
NCT02619877 ·Status: COMPLETED ·Phase: PHASE2
-
Stem Cell Study for Patients With Leg Ulcer/Gangrene
NCT00221143 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-Term Follow-Up to the DEVO Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers
NCT01891760 ·Status: COMPLETED ·Phase: PHASE3
-
Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
NCT00662831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Prospective Study of Endothelial Dysfunction and Diabetic Foot Ulcer Risk
NCT00013286 ·Status: COMPLETED
-
Effect of NIRS-assisted Assessment on Chronic Lower Extremity and Other Chronic Non-healing Ulcers
NCT06702852 ·Status: TERMINATED ·Phase: NA
-
PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer
NCT03248466 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers
NCT06852976 ·Status: RECRUITING ·Phase: PHASE2
-
A Prospective, Randomized, Controlled, Multi-Center, Study Evaluating AutoloGel Therapy for Complete Closure of Wagner Grade 1-4 Diabetic Foot Ulcers, Venous Leg Ulcers and Stage II-IV Pressure Ulcers
NCT02248077 ·Status: WITHDRAWN ·Phase: PHASE4
-
Assessment of the Efficacy and Tolerance of Sub-cutaneous Re-injection of Autologous Adipose-derived REGEnerative Cells in the Local Treatment of Neuropathic Diabetic Foot ulcERs
NCT02866565 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Autologous Platelet-Rich Plasma Therapy in the Treatment of Pyoderma Gangrenosum
NCT05984654 ·Status: WITHDRAWN ·Phase: NA
-
Shockwave Therapy of Chronic Diabetic Foot Ulcers
NCT02251418 ·Status: COMPLETED ·Phase: NA
-
Bioactive Split Thickness Skin Allograft Versus Standard of Care in the Treatment of Diabetic Foot Ulcers
NCT04040426 ·Status: COMPLETED ·Phase: NA
-
Efficacy of ProgenaMatrix™ in the Management of DFUs
NCT06292026 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Research to Evaluate Efficiency in U-health Solution Service for the Chronic Wound Management
NCT02382302 ·Status: COMPLETED ·Phase: NA
-
Intensive Glycemic Control For Diabetic Foot Ulcer Healing
NCT04323462 ·Status: UNKNOWN ·Phase: PHASE4
-
Umbilical Cord Blood Mononuclear Cell Gel in the Treatment of Refractory Diabetic Foot Ulcer
NCT04689425 ·Status: UNKNOWN ·Phase: PHASE3
-
Effectiveness of the EmoLED Medical Device in the Healing of Digital Ulcers in Patients With Scleroderma.
NCT05181644 ·Status: TERMINATED ·Phase: NA
-
Autologous Platelet Rich Plasma (PRP) for the Treatment of Chronic Non-Healing Ulcers
NCT03026855 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
NCT04569409 ·Status: COMPLETED ·Phase: PHASE3
-
Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers
NCT06680856 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety & Efficacy Study for the Use of Extracorporeal Shockwaves in the Treatment of Diabetic Foot Ulcers
NCT00366132 ·Status: UNKNOWN ·Phase: PHASE2
-
Cutaneous Microcirculation After Extracorporeal Shock Wave Therapy
NCT02417779 ·Status: COMPLETED ·Phase: NA